Inactive Instrument

Press Releases Cytokinetics, Inc. Nasdaq

Equities

US23282W1009

End-of-day quote Nasdaq Other stock markets
- ^USD	-

Apr. 26	Cytokinetics Appoints Sung Lee as CFO	MT
Apr. 26	Cytokinetics, Incorporated Appoints Sung H. Lee as Executive Vice President, Effective as of May 8, 2024	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cytokinetics to Host Investor Event and Conference Call to Discuss the Primary Results From SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024 Congress	Apr. 29	AQ
Cytokinetics to Announce First Quarter Results on May 8, 2024	Apr. 24	AQ
Cytokinetics Announces Three Late Breaking Clinical Trial Presentations Relating to SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024 Congress	Apr. 10	AQ
Cytokinetics Presents Additional 48-Week Data From FOREST-HCM, the Open Label Extension Clinical Study of Aficamten, at The American College of Cardiology 73ʳᵈ Annual Scientific Session	Apr. 05	AQ
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	Apr. 02	AQ
Cytokinetics to Participate in the 23rd Annual Needham Virtual Healthcare Conference	Apr. 01	AQ
Cytokinetics Announces Four Upcoming Presentations at the American College of Cardiology 73rd Annual Scientific Session	Mar. 25	AQ
Cytokinetics to Participate in March Investor Conferences	Mar. 04	AQ
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	Mar. 01	AQ
Cytokinetics Joins Global Initiative to Recognize International Rare Disease Day	Feb. 29	AQ
Cytokinetics, The Mended Hearts, Inc. and WomenHeart Announce Launch of New Initiative to Increase Engagement in Cardiovascular Clinical Trials	Feb. 28	AQ
Cytokinetics: Q4 Earnings Snapshot	Feb. 27	AQ
Cytokinetics Reports Fourth Quarter 2023 Financial Results	Feb. 27	AQ
Cytokinetics to Announce Fourth Quarter Results on February 27, 2024	Feb. 13	AQ
Cytokinetics to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference	Feb. 06	AQ
Cytokinetics Announces Recipients of Its Sixth Annual Communications Grant Program	Jan. 29	AQ
Cytokinetics Presents New Data at CMR 2024 From FOREST-HCM, the Open Label Extension Clinical Trial of Aficamten	Jan. 25	AQ
Cytokinetics Announces New Data From FOREST-HCM to be Presented at CMR 2024	Jan. 18	AQ
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	Jan. 03	AQ
Cytokinetics to Present at the 42nd Annual J.P. Morgan Healthcare Conference	Jan. 02	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Cytokinetics, Inc. Nasdaq

Equities

US23282W1009

Press Releases

Filters